The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth
Open accessAbstract
Candida albicans causes superficial and life-threatening systemic infections. These are difficult to treat often due to drug resistance, particularly because C. albicans biofilms are inherently resistant to most antifungals. Sophorolipid (SL), a glycolipid biosurfactant, has been shown to have antimicrobial and anticancer properties. In this study, we investigated the effect of SL on C. albicans biofilm formation and preformed biofilms. SL was found to inhibit C. albicans biofilm formation as well as reduce the viability of preformed biofilms. Moreover, SL, when used along with amphotericin B (AmB) or fluconazole (FLZ), was found to act synergistically against biofilm formation and preformed biofilms. Effect of SL on C. albicans biofilm formation was further visualized by scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM), which revealed absence of hyphae, typical biofilm architecture and alteration in the morphology of biofilm cells. We also found that SL downregulates the expression of hypha specific genes HWP1, ALS1, ALS3, ECE1 and SAP4, which possibly explains the inhibitory effect of SL on hyphae and biofilm formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
Growth of Candida albicans hyphae
Sudbery, P. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2636 · Cited by 1,110
Emerging opportunistic yeast infections
Miceli, M. H., Díaz, J. A., & Lee, S. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70218-8 · Cited by 811
Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793
Candida albicans: A molecular revolution built on lessons from budding yeast
Berman, J., & Sudbery, P. E. (2002) · Nature Reviews Genetics · doi:10.1038/nrg948 · Cited by 578
Combination antifungal therapy
Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., & Rex, J. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.693-715.2004 · Cited by 541
Critical Role of Bcr1-Dependent Adhesins in C. albicans Biofilm Formation In Vitro and In Vivo
Nobile, C. J., Andes, D. R., Nett, J. E., Smith, F. J., Yue, F., Phan, Q.-T., Edwards, J. E., Filler, S. G., & Mitchell, A. P. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020063 · Cited by 507
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Cited by
Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health
Chee, W. J. Y., Chew, S. Y., & Than, L. T. L. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01464-4 · Cited by 657
Jahan, R., Bodratti, A. M., Tsianou, M., & Alexandridis, P. (2020) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.102061 · Cited by 565
Natural Anti-biofilm Agents: Strategies to Control Biofilm-Forming Pathogens
Mishra, R., Panda, A. K., De Mandal, S., Shakeel, M., Bisht, S. S., & Khan, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.566325 · Cited by 449
Microbial biosurfactants: current trends and applications in agricultural and biomedical industries
Naughton, P. J., Marchant, R., Naughton, V., & Banat, I. M. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14243 · Cited by 343
Sen, S., Borah, S. N., Bora, A., & Deka, S. (2017) · Microbial Cell Factories · doi:10.1186/s12934-017-0711-z · Cited by 205
“However, the antimicrobial activity has been described mostly against bacteria and in some cases against yeasts [11, 12].”
BackgroundEmerging Antifungal Targets and Strategies
Ivanov, M., Ćirić, A., & Stojković, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052756 · Cited by 160
Sun, L., Liao, K., Hang, C., & Wang, D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0172228 · Cited by 105
From bumblebee to bioeconomy: Recent developments and perspectives for sophorolipid biosynthesis
Dierickx, S., Castelein, M., Remmery, J., De Clercq, V., Lodens, S., Baccile, N., De Maeseneire, S. L., Roelants, S. L. K. W., & Soetaert, W. K. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107788 · Cited by 88
Huang, X., Yi, Y., Yong, J., Sun, J., Song, Z., Li, D., & Li, Y. (2021) · The Journal of Antibiotics · doi:10.1038/s41429-021-00463-w · Cited by 33
Mohammad, H., Elghazawy, N. H., Eldesouky, H. E., Hegazy, Y. A., Younis, W., Avrimova, L., Hazbun, T., Arafa, R. K., & Seleem, M. N. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00215 · Cited by 29
Li, Y., Shan, M., Yan, M., Yao, H., Wang, Y., Gu, B., Zhu, Z., & Li, H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02844 · Cited by 16
Gizińska, M., Staniszewska, M., & Ochal, Z. (2018) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557518666180924121209 · Cited by 15
Metadata
- Authors
- Haque, F., Alfatah, M., Ganesan, K., & Bhattacharyya, M. S.
- Venue
- Scientific Reports
- Published
- 2016-03-31
- Volume
- 6
- Issue
- 1
- Pages
- 23575-23575
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2331364879
- Cited by
- 189
- References
- 14
- FWCI
- 14.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.